2024 ISPE Europe Annual Conference

Conference Overview

This European Annual Conference draws pharmaceutical and biopharmaceutical professionals at all levels of the industry - from students and emerging leaders to the most senior executives in drug manufacturing, supply chain, devices, equipment and services, and global regulatory agencies. We welcome you to participate at the 2024 ISPE Europe Annual Conference to learn and share progress, success stories, best practices and lessons learned.


Conference Topics

The 2024 Europe Annual Conference Programme Committee is requesting proposals aligning with the following content areas:



Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2024 ISPE Europe Annual Conference.

Name
Company Type
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Program Committee

Udo J. Vetter
Head of the Advisory Board
Vetter Pharma International GmbH
Executive Chair
Cristina Mazó
Site Manager
ISPE Iberia Affiliate
Conference Chair
Michael A.M. ATZOR, PhD
Managing Director
ISPE D/A/CH
Mark Birse
Vice President Technical
Parexel
David Churchward
Global Head Sterility Assurance, Cell and Gene Technologies
Lonza Biologics
Richard Denk
Senior Consultant Aseptic Processing & Containment
SKAN AG
Yvonne Duckworth, PE
Fellow - Digital Technology, Associate
CRB
Jean Francois Duliere
Reg Advisor
ISPE
David Estapé, PhD
Technology Manager Biotechnology
CRB Group GmbH
Frank Henrichmann
Sr. Exec. Consultant
QFINITY
Oliver Herrmann
CEO
QFINITY
Teresa Minero
Founder & CEO
LifeBee - Digitalizing Life Sciences
Alice Redmond, PhD
Chief Strategy Officer
CAI
Søren Thuesen Pedersen
Senior Director, External Affairs, Quality Intelligence & Inspection
Novo Nordisk
Heather D. Watson
Director
TenTenTen Consulting Ltd
Christian Wölbeling
Executive Industry Advisor
Körber Pharma Software GmbH